JRF Vacancy @ Shiv Nadar University

JRF Vacancy @ Shiv Nadar University With Attractive Fellowship in Dept of Life Science

0
JRF Vacancy @ Shiv Nadar University With Attractive Fellowship in Dept of Life Science  DEPARTMENT OF LIFE SCIENCES SCHOOL OF NATURAL SCIENCES SHIV NADAR UNIVERSITY Applications are invited...
Biotecnika Newsletter | ICGEB PhD Fellowship & Biotech Job @ DRDO

Biotecnika Times – Newsletter 13.10.2017

0
PhD Admission - Karnatak University 2017-2018 | Full Time & Part Time Courses Applications for admission to the degree of Doctor of Philosophy (Ph.D.) in...
Celyad CAR-T Approach Clears Patient of Cancer in Phase 1

Celyad CAR-T Approach Clears Patient of Cancer in Phase 1

0
Celyad CAR-T Approach Clears Patient of Cancer in Phase 1 Celyad's T-cell immunotherapy approach is unique and builds on work conducted by Professor Charles Sentman and his team...

Life Science Lecturer Post Vacant @ Biotecnika – Chennai | Apply Now

0
Life Science Lecturer Post Vacant @ Biotecnika - Chennai | Apply Now BioTecNika Info Labs Pvt Ltd which runs India's Largest Biosciences Career & education...
New Tissue Regeneration Method Inspired By Nature

New Tissue Regeneration Method Inspired By Nature

0
New Tissue Regeneration Method Inspired By Nature Scientists at the University of Birmingham have now found a way of mimicking our body’s natural healing process,...
proposals open @ inStem

Proposals Open @ inStem, Bangalore – Cohort Monitoring and Management

0
Proposals Open @ inStem, Bangalore - Cohort Monitoring and Management Status of Position: Open Proposals are invited for Cohort Monitoring and Management of the clinical component of...
Astrazeneca’s Lung Cancer Drug Granted Breakthrough Therapy Designation In First-Line NSCLC

Astrazeneca’s Lung Cancer Drug Granted Breakthrough Therapy Designation In First-Line NSCLC

0
AstraZeneca's Lung Cancer Drug Granted Breakthrough Therapy AstraZeneca, the Anglo-Swedish pharma major, has now been awarded breakthrough status in the US for its drug candidate,...

PhD Admission – Karnatak University 2017-2018 | Full Time & Part Time Courses

1
PhD Admission - Karnatak University 2017-2018. Full Time & Part Time Courses Applications for admission to the degree of Doctor of Philosophy (Ph.D.) in the...
Atomo HIV Self-Test Granted CE Mark by EU

Atomo HIV Self-Test Granted CE Mark by EU

0
Atomo HIV Self-Test Granted CE Mark by European Union A world leader in innovative point-of-care, rapid diagnostic devices, Atomo Diagnostics, has now received CE Marking by...
Scientists Implant Stem-Cell-Derived Small Bowel Segments Into Rats

Scientists Implant Stem-Cell-Derived Small Bowel Segments Into Rats

0
Scientists Implant Stem-Cell-Derived Small Bowel Segments Into Rats Short bowel syndrome (SBS) is the end-stage pathology of various gastrointestinal disorders, including Crohn’s disease, mesenteric ischemia,...

Biotecnika Times – 12.10.2017

0
Research Fellowships - Swiss Government Excellence Scholarships 2018 The Swiss Government via the Federal Commission for Scholarships for Foreign Students FCS.............. Read More PhD Admissions - Saha Institute...

Amgen, CytomX Enter Strategic Alliance To Dig Deeper Into I-O

0
Amgen, CytomX Enter Strategic Alliance To Dig Deeper Into I-O California-based multinational pharmaceutical firm, Amgen has now partnered with CytomX Therapeutics to develop and commercialize...
Scientist To Distribute Synthego’s Guide RNA Products For CRISPR

Thermo Fisher Scientific To Distribute Synthego’s Synthetic Guide RNA Products For CRISPR Genome Engineering

0
Scientist To Distribute Synthego’s Guide RNA Products For CRISPR A leading provider of genome engineering solutions, Synthego, has now announced a new alignment with Thermo...

Lonza Acquires Shire’s California Site to Expand Presence in Mammalian Manufacturing

0
Shire’s California Site to Expand Presence in Mammalian Manufacturing Swiss CDMO Lonza, in order to expand its presence in the mammalian manufacturing scene, is now...

Gilead Licenses Generic Production of its HIV-1 Treatment Bictegravir to Medicines Patent Pool

0
Gilead Licenses Generic Production of its HIV-1 Treatment California-based Gilead Sciences Inc., has now announced a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed...